Acutus Medical Valuation
| AFIBDelisted Stock | USD 0.73 0.03 3.95% |
Acutus Medical is overvalued. Acutus Medical shows a prevailing Real Value of $0.68 per share. The current price of the firm is $0.73. Our model approximates the value of Acutus Medical from analyzing the firm fundamentals such as Operating Margin of (2.89) %, return on equity of -0.32, and Shares Outstanding of 29.72 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Acutus Medical's price fluctuation is very steady at this time. Calculation of the real value of Acutus Medical is based on 3 months time horizon. Increasing Acutus Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Acutus Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Acutus Stock. However, Acutus Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.73 | Real 0.68 | Hype 0.73 |
The real value of Acutus Stock, also known as its intrinsic value, is the underlying worth of Acutus Medical Company, which is reflected in its stock price. It is based on Acutus Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Acutus Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Acutus Medical helps investors to forecast how Acutus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Acutus Medical more accurately as focusing exclusively on Acutus Medical's fundamentals will not take into account other important factors: Acutus Medical Total Value Analysis
Acutus Medical is presently forecasted to have valuation of 18.75 M with market capitalization of 2.67 M, debt of 38.48 M, and cash on hands of 88.97 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Acutus Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
18.75 M | 2.67 M | 38.48 M | 88.97 M |
Acutus Medical Investor Information
About 24.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.53. Some equities with similar Price to Book (P/B) outperform the market in the long run. Acutus Medical recorded a loss per share of 0.41. The entity had not issued any dividends in recent years. Acutus Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Acutus Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Acutus Medical has an asset utilization ratio of 13.28 percent. This suggests that the Company is making $0.13 for each dollar of assets. An increasing asset utilization means that Acutus Medical is more efficient with each dollar of assets it utilizes for everyday operations.Acutus Medical Ownership Allocation
Acutus Medical holds a total of 29.72 Million outstanding shares. Acutus Medical shows 3.15 percent of its outstanding shares held by insiders and 23.5 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Acutus Medical Profitability Analysis
The company reported the previous year's revenue of 7.16 M. Net Loss for the year was (11.92 M) with loss before overhead, payroll, taxes, and interest of (15.55 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Acutus Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Acutus Medical and how it compares across the competition.
About Acutus Medical Valuation
The delisted stock valuation mechanism determines Acutus Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Acutus Medical. We calculate exposure to Acutus Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Acutus Medical's related companies.Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California. Acutus Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 338 people.
Acutus Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 29.1 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Acutus Stock
If you are still planning to invest in Acutus Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acutus Medical's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |